What question did this study set out to answer?

This research aims to evaluate how digital health services can help prevent sarcopenia in older adults.

April 17, 2026

HQ4 : Do Interventions and Assessments That Use Digital Health Services Prevent Sarcopenia in Older Adults?: English Translation of the Japanese Guideline for Digital Health for the Prevention and Improvement of Sarcopenia and Frailty

KMKeisuke MaedaAichi Medical University Hospital KIKatsuya IijimaTokyo Future University HMHyuma MakizakoKagoshima University

Key Points

This research aims to evaluate how digital health services can help prevent sarcopenia in older adults.
Review of existing guidelines on digital health for sarcopenia prevention.
Translation of Japanese guidelines into English for accessibility.
Analysis of interventions that utilize digital platforms.
Highlighting the effectiveness of digital health in assessing muscle health.
Recommending guidelines for practical applications in older populations.
Indicating the potential of digital services to enhance health outcomes.

Abstract

K.I. has disclosed financial relationships with Prudential Gibraltar Financial Life Insurance Co. Ltd., Kanagawa Prefecture, NTT Docomo Inc., WELMO Co. Ltd., Hitachi Ltd., Tokyo Gas Co. Ltd., LOTTE Co. Ltd., Sunstar Inc., WELMO Co. Ltd., Maruta Foods Co. Ltd., Kewpie Corporation, EON Co. Ltd., Industry–Academia Co-creation/2021 “Habitat Innovation” Project (Hitachi Ltd.). M.A. has disclosed financial relationships with Daiichi Sankyo Co. Ltd., MSD K.K., Toa Eiyo Co. Ltd., Towa Pharmaceutical Co. Ltd., Eisai Co. Ltd., Kracie Pharmaceutical Co. Ltd., Tsumura Pharmaceutical Co. Ltd., Tanabe Mitsubishi Pharma Corporation, Chugai Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., Bayer Yakuhin Ltd. The other authors declare no conflicts of interest.

AI से पूछें

Bookmark

View Full Paper